SCHEMBL147026

SCHEMBL147026

CC(C)Oc1[c]c(OC(C)C)ccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
MCHR1 Q99705 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
ALDH1A3 P47895 1/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA7 P43166 2/20 0.32
CA9 Q16790 2/20 0.32
KMT2A Q03164 2/20 0.31
CA12 O43570 1/20 0.31
CA14 Q9ULX7 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ACHE P22303 1/20 0.31
SCN4A P35499 3/20 0.30
PARP10 Q53GL7 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159441 0.91 NPSR1 (0.33) RXRARXRBMCHR1ALDH1A1NPSR1
SCHEMBL11503971 0.86 SCN4A (0.31) MCHR1SCN4ALMNACYP1A2CYP3A4
SCHEMBL4536424 0.84
SCHEMBL25185702 0.84 CSNK2A1 (0.30)
SCHEMBL8531611 0.84
SCHEMBL11503560 0.83 ADRA2A (0.30)
SCHEMBL28804105 0.80 CYP2C19 (0.34) RXRARXRBKMT2AALDH1A1LMNA
SCHEMBL27598494 0.80 KDM4E (0.35) KMT2AALDH1A1LMNATSHRMEN1
SCHEMBL17714525 0.80 RXRA (0.35) RXRARXRBKMT2AALDH1A1LMNA
SCHEMBL11504390 0.78 TSHR (0.32) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024060641-A1 CYCLOTRIARYLPHOSPHINE, METHOD FOR PREPARING SAME, AND USE THEREOF 东莞市均成高新材料有限公司 2024-03-28 WO claimed
US-11787827-B2 Triaryl phosphine ligands, preparation method therefor, and use in catalyzing coupling reactions DONGGUAN STEPHEN CATALYST CO., LTD. (CN) 2023-10-17 US claimed
CN-115850329-A Cycloterpyriaryl phosphines, their preparation and use 东莞市均成高新材料有限公司 2023-03-28 CN claimed
CN-115385956-A Biaryl diphosphine ligands and transition metal complexes thereof 东莞市均成高新材料有限公司 2022-11-25 CN claimed
CN-115385957-A Linear terphenyl aryl phosphine ligand and transition metal complex thereof 东莞市均成高新材料有限公司 2022-11-25 CN claimed
EP-4017862-A1 BIS(PHOSPHINO)-PHENOXY NICKEL(II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND ACRYLATE MONOMERS Dow Global Technologies LLC (US) 2022-06-29 EP claimed
CN-114206956-A Bis (phosphino) -phenoxynickel (II) catalysts for copolymerization of ethylene and acrylate monomers 陶氏环球技术有限责任公司 2022-03-18 CN claimed
US-20210147452-A1 TRIARYL PHOSPHINE LIGANDS, PREPARATION METHOD THEREFOR, AND USE IN CATALYSING COUPLING REACTIONS DONGGUAN STEPHEN CATALYST CO., LTD. (CN) 2021-05-20 US claimed
CN-110240616-B Tribiaryl monophosphine ligands, methods for their preparation and use in catalytic coupling reactions 东莞市均成高新材料有限公司 2021-03-23 CN claimed
WO-2021034809-A1 BIS(PHOSPHINO)-PHENOXY NICKEL(II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND ACRYLATE MONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2021-02-25 WO claimed
US-9611348-B2 Process of producing polyolefins using metallocene polymerization catalysts and copolymers therefrom EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-04-04 US claimed
EP-2984111-A1 PROCESS OF PRODUCING POLYOLEFINS USING METALLOCENE POLYMERIZATION CATALYSTS AND COPOLYMERS THEREFROM ExxonMobil Chemical Patents Inc. (US) 2016-02-17 EP claimed
CN-105263969-A Process of producing polyolefins using metallocene polymerization catalysts and copolymers therefrom EXXONMOBIL CHEM PATENTS INC 2016-01-20 CN claimed
US-20140316085-A1 Process of Producing Polyolefins Using Metallocene Polymerization Catalysts and Copolymers Therefrom EXXONMOBIL CHEMICAL PATENTS INC. 2014-10-23 US claimed
WO-2014169017-A1 PROCESS OF PRODUCING POLYOLEFINS USING METALLOCENE POLYMERIZATION CATALYSTS AND COPOLYMERS THEREFROM EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-10-16 WO claimed
US-8039625-B2 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2011-10-18 US claimed
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF NATIONAL SCIENCE FOUNDATION 2009-02-19 US claimed
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof GEORGIA TECH RESEARCH CORPORATION 2008-09-18 US claimed
WO-2006093965-A2 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2006-09-08 WO claimed
WO-2005124453-A2 PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2005-12-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787827-B2 Triaryl phosphine ligands, preparation method therefor, and use in catalyzing coupling reactions WEE1, WEE2, NOTUM RXRA 3441/4885RXRB 3220/4885MCHR1 2543/4885
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof SLC43A1, SLC3A2, SLC16A3 RXRA 3751/4885RXRB 3831/4885MCHR1 3868/4885
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF SLC18A3, CORO1C, SLC18A1 RXRA 3640/4885RXRB 4075/4885MCHR1 3509/4885
US-20210147452-A1 TRIARYL PHOSPHINE LIGANDS, PREPARATION METHOD THEREFOR, AND USE IN CATALYSING COUPLING REACTIONS WEE1, WEE2, NOTUM RXRA 3429/4885RXRB 3146/4885MCHR1 2703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.